Select login type
xCHOOSE A PAGE TO ACCESS
x- WGXVI Development Safety Update Report Working Group Documents
- Pharmacoepidemiology for Public Health Working Group Documents
- WGXII Benefit-risk Working Group Documents
- Good Governance Practice for Research Institutions Working Group Documents
- Educational Standards Working Group Documents
- SCAR Working Group Documents
- WGXIII Real-world Data Working Group Documents
- WGXII Benefit-risk Working Group Documents
- MedDRA Labelling Groupings Working Group Documents
- WGXI Patient Involvement: Workplans, drafts, TC notes ...
- WGXI Patient Involvement: Background Documents
- WGXI Patient Involvement: Face-to-face meetings
- Clinical Research in Resource-limited Settings Working Group Documents
- Login
Fluconazole-induced liver injury in patients with pulmonary cryptococcosis: a comprehensive study integrating clinical cohort analysis, network toxicology, molecular docking, and transcriptomics
- Home
- Fluconazole-induced liver injury in patients with pulmonary cryptococcosis: a comprehensive study integrating clinical cohort analysis, network toxicology, molecular docking, and transcriptomics
Fluconazole is key for pulmonary cryptococcosis (PC), but its hepatotoxicity
(HT) risk is unclear. This study characterized fluconazole-induced liver injury in HIV-neg
ative PC patients and explored its mechanism.